SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance

July 2023 in “ Life ”

Gabriela Mariana Iancu, Eszter Molnár, Loredana Ungureanu, Simona Corina Șenilă, Adrian Hașegan, Maria Rotaru

Telogen Effluvium SARS-CoV-2 COVID-19 physiological stress vitamin supplements topical Minoxidil 2% solution hair-fortifying shampoos psychological support alopecia dermatological treatment TE Minoxidil Rogaine

TLDR COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The document is a review of literature and a case study on Telogen Effluvium (TE), a temporary hair loss condition triggered by SARS-CoV-2 infection (COVID-19). The document suggests that COVID-19 can cause TE due to the physiological stress it places on the body. A case study of a 48-year-old female patient showed complete hair recovery after eight months of treatment with vitamin supplements, topical Minoxidil 2% solution, and hair-fortifying shampoos, along with psychological support. The document also discusses various studies, one of which found that 25% of COVID-19 patients experienced alopecia during recovery. Another study showed that TE typically starts 45 days after infection and lasts for an average of 47.5 days. The document concludes that TE post-COVID-19 is a common but reversible condition with appropriate dermatological treatment.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

30 / 30 results

research Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 Participants

2 citations , January 2023 in “Dermatology practical & conceptual”

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

research Telogen Effluvium After COVID-19 Vaccination Among Public in Saudi Arabia

4 citations , October 2022 in “Journal of family medicine and primary care”

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

research Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia

2 citations , September 2022 in “Cureus”

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies

3 citations , August 2022 in “International Journal of Molecular Sciences”

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19

2 citations , August 2022 in “Clinical Case Reports”

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review

12 citations , July 2022 in “Journal of Cosmetic Dermatology”

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

research Covid Induced Telogen Effluvium: An Insight

4 citations , June 2022 in “Indian Dermatology Online Journal”

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

7 citations , May 2022 in “The Journal of Dermatology”

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis

6 citations , May 2022 in “Frontiers in Medicine”

The study suggests pandemic stress might worsen or trigger hair loss problems.

research Epidemiological, Clinical, and Trichoscopic Features of Syphilitic Alopecia: A Retrospective Analysis and Systematic Review

4 citations , May 2022 in “Frontiers in Medicine”

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity

8 citations , May 2022 in “Journal of medicine and life”

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

3 citations , April 2022 in “Clinical, Cosmetic and Investigational Dermatology”

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication

8 citations , February 2022 in “Journal of Clinical Medicine”

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

4 citations , February 2022 in “Journal of Cosmetic Dermatology”

Monocytes might be linked to hair loss after COVID-19.

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research COVID-19 Induced Telogen Effluvium

22 citations , October 2021 in “Dermatologic Therapy”

COVID-19 may cause temporary hair loss in some people.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , July 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research The Antiandrogen Enzalutamide Downregulates TMPRSS2 and Reduces Cellular Entry of SARS-CoV-2 in Human Lung Cells

50 citations , July 2021 in “Nature Communications”

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

research Diagnostic Accuracy of Trichoscopy in Trichotillomania: A Systematic Review

8 citations , June 2021 in “Acta dermato-venereologica”

Trichoscopy is a reliable method for diagnosing hair-pulling disorder.

research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

14 citations , April 2021 in “Clinical, Cosmetic and Investigational Dermatology”

COVID-19 may trigger sudden temporary hair loss.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

28 citations , January 2021 in “Skin appendage disorders”

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

research Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review

101 citations , July 2020 in “Dermatologic therapy”

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

research Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review

66 citations , June 2018 in “International Journal of Women's Dermatology”

No cure for female pattern hair loss, but various effective treatments exist.

research Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

31 citations , January 2016 in “Drugs - Real World Outcomes”

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

research An Overview of Management of Drug-Induced Hair and Nail Disorders

7 citations , May 2014 in “Clinical practice”

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

research Trichoscopy in Alopecias: Diagnosis Simplified

96 citations , January 2013 in “International Journal of Trichology”

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Related Research

9 / 9 results

research Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss

1 citations , January 2022 in “Dermatology Reports”

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

research Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata

2 citations , September 2021 in “JAAD case reports”

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

research A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan

6 citations , July 2019 in “Indian Journal of Dermatology”

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus